SABSW
USDSAB Biotherapeutics Inc. Warrant
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$0.048
High
$0.039
Low
$0.028
Volume
0.01M
Company Fundamentals
Industry
Biotechnology
Country
United States
Trading Stats
Exchange
NCM
Currency
USD
52-Week Range
Related News
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
Related Stocks
MVT
Blackrock MuniVest Fund II Inc.
MRO
Marathon Oil Corporation
BRFH
Barfresh Food Group Inc.
CLDX
Celldex Therapeutics Inc.
PNFPP
Pinnacle Financial Partners Inc. Depositary shares of Pinnacle Financial Partners Inc. each representing a 1/40th Interest in a share of its 6.75% Fixed-Rate Non-Cumulative Perpetual Preferred Stock Series B
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.